13F Holdings
中文EN

PNTG Pennant Group, Inc.

Services-Health Services · Nasdaq · SEC CIK 1766400 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY38.7%
TTM net income YoY34.4%
TTM EPS YoY34.7%
Revenue 3-yr CAGR30.9%
Net income 3-yr CAGR42.1%

Margins

Gross margin18.3%
Operating margin5.8%
Net margin3.1%
FCF margin2.9%
EBITDA margin6.8%

Returns

ROE10.3%
ROA4.0%
ROIC (approx.)11.3%
Asset turnover1.31x

Leverage & solvency

Liabilities / assets59.7%
Debt / equity0.53x
Current ratio1.18x
Interest coverage5.15x

Cash quality & payout

Operating cash flow / net income1.80x
Accruals ratio-3.2%
Payout ratio—
Capex / revenue2.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$947.71M$695.24M$544.89M$473.24M$439.69M
Cost of revenue$768.50M$558.45M$438.10M$376.64M$350.24M
Gross profit$179.20M$136.79M$106.80M$96.60M$89.46M
SG&A expense$71.08M$50.21M$36.67M$33.98M$36.26M
Operating income$51.89M$38.12M$25.17M$12.74M$4.70M
Interest expense$6.68M$6.96M$5.92M$3.82M$1.94M
Pretax income$45.63M$31.37M$19.58M$8.89M$2.73M
Income tax$11.87M$7.03M$5.67M$1.65M$582,000
Net income$29.58M$22.56M$13.38M$6.64M$2.70M
EBITDA$60.42M$44.23M$30.30M$17.64M$9.48M
EPS (basic)0.860.720.450.230.09
EPS (diluted)0.840.700.440.220.09
Weighted avg. shares (diluted)35.32M32.00M30.19M30.16M30.64M
Balance sheet
Cash & equivalents$17.02M$24.25M$6.06M$2.08M$5.19M
Receivables$123.11M$81.30M$61.12M$53.42M$53.94M
Current assets$167.41M$122.86M$80.08M$73.82M$75.84M
PP&E, net$60.98M$43.30M$28.60M$26.62M$16.79M
Goodwill$237.25M$129.12M$91.01M$79.50M$74.27M
Total assets$968.18M$679.52M$539.69M$512.12M$530.30M
Current liabilities$147.26M$101.70M$71.55M$70.25M$71.64M
Short-term debt$5.00M$0———
Long-term debt$168.84M$0$63.91M$62.89M$51.37M
Total debt$173.84M$0$63.91M$62.89M$51.37M
Total liabilities$593.93M$367.56M$394.18M$386.46M$416.05M
Shareholders' equity$332.60M$293.28M$140.34M$121.01M$110.20M
Net debt$156.81M-$24.25M$57.85M$60.81M$46.18M
Shares outstanding34.63M34.37M29.95M29.69M28.50M
Cash flow statement
Operating cash flow$48.29M$39.30M$33.09M$9.04M-$18.22M
Capital expenditure$12.04M$8.99M$8.11M$14.17M$6.30M
Free cash flow$36.26M$30.31M$24.98M-$5.13M-$24.53M
Investing cash flow-$227.97M-$70.68M-$30.22M-$24.24M-$20.12M
Financing cash flow$172.46M$49.57M$1.11M$12.08M$43.49M
Depreciation & amortization$8.54M$6.12M$5.13M$4.90M$4.78M
Stock-based compensation$8.94M$7.78M$5.37M$3.09M$10.04M
Dividends paid————$0
Share buybacks———$0$0

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.